Immunotherapy for treating methamphetamine, heroin and cocaine use disorders
- 1 March 2020
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 25 (3) , 610-619
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 55 references indexed in Scilit:
- Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active MetabolitesPLOS ONE, 2013
- An Antidote for Acute Cocaine ToxicityMolecular Pharmaceutics, 2012
- Novel Cocaine Vaccine Linked to a Disrupted Adenovirus Gene Transfer Vector Blocks Cocaine Psychostimulant and Reinforcing EffectsNeuropsychopharmacology, 2011
- A Vaccine Strategy that Induces Protective Immunity against HeroinJournal of Medicinal Chemistry, 2011
- Impact of Distinct Chemical Structures for the Development of a Methamphetamine VaccineJournal of the American Chemical Society, 2011
- Cocaine Analog Coupled to Disrupted Adenovirus: A Vaccine Strategy to Evoke High-titer Immunity Against Addictive DrugsMolecular Therapy, 2011
- Cocaine-Specific Antibodies Blunt the Subjective Effects of Smoked Cocaine in HumansBiological Psychiatry, 2010
- The Synthesis of Haptens and Their Use for the Development of Monoclonal Antibodies for Treating Methamphetamine AbuseJournal of Medicinal Chemistry, 2009
- Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in ratsVaccine, 2009
- Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse—Methamphetamine and 3,4‐methylenedioxymethamphetamineProtein Science, 2009